WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABOS

Based on 3 analysts offering 12 month price targets for Acumen Pharmaceuticals Inc.
Min Forecast
$13.00+162.63%
Avg Forecast
$13.67+176.1%
Max Forecast
$15.00+203.03%

Should I buy or sell ABOS stock?

Based on 3 analysts offering ratings for Acumen Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABOS stock forecasts and price targets.

ABOS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 13%
13
Strong BuyInitiates Coverage On$13.00+162.63%2023-05-18
Credit Suisse
Top 15%
86
BuyMaintains$13.00+162.63%2023-03-28
HC Wainwright & Co.
Top 10%
91
BuyReiterates$15.00+203.03%2023-03-28

1 of 1

Forecast return on equity

Is ABOS forecast to generate an efficient return?
Company
-28.41%
Industry
29.59%
Market
89.57%
ABOS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ABOS forecast to generate an efficient return on assets?
Company
-27.08%
Industry
11.76%
ABOS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ABOS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABOS$4.95$13.67+176.10%Strong Buy
BIVI$5.59$11.50+105.72%Strong Buy
VSTM$12.05$28.00+132.37%Buy
PDSB$6.53$19.00+190.96%Strong Buy
CTXR$1.29$6.00+365.12%Buy
View Top Biotech Stocks

Acumen Pharmaceuticals Stock Forecast FAQ

Is Acumen Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ABOS) stock is to Strong Buy ABOS stock.

Out of 3 analysts, 1 (33.33%) are recommending ABOS as a Strong Buy, 2 (66.67%) are recommending ABOS as a Buy, 0 (0%) are recommending ABOS as a Hold, 0 (0%) are recommending ABOS as a Sell, and 0 (0%) are recommending ABOS as a Strong Sell.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.

What is ABOS's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: ABOS) forecast ROE is -28.41%, which is considered weak.

What is ABOS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ABOS price target, the average ABOS price target is $13.67, with the highest ABOS stock price forecast at $15.00 and the lowest ABOS stock price forecast at $13.00.

On average, Wall Street analysts predict that Acumen Pharmaceuticals's share price could reach $13.67 by May 18, 2024. The average Acumen Pharmaceuticals stock price prediction forecasts a potential upside of 176.1% from the current ABOS share price of $4.95.

What is ABOS's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: ABOS) forecast ROA is -27.08%, which is lower than the forecast US Biotechnology industry average of 11.76%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.